2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
June 25, 2025
Video
Douglas B. Johnson, MD, MSCI, highlighted avenues for improving immunotherapy use in melanoma during Cancer Immunotherapy Awareness Month.
June 12, 2025
Article
Obrixtamig combined with topotecan demonstrated favorable safety and early efficacy in relapsed/refractory SCLC.
May 28, 2025
Video
Ryan T. Merrell, MD, discusses current treatment modalities for gliomas in recognition of Brain Tumor Awareness Month.
May 28, 2025
Article
Ryan Merrell, MD, underscores the need for early glioma detection, advances in IDH-targeted therapy, and emerging immunotherapy in glioblastoma care.
March 24, 2025
Article
Jill Gilbert, MD, discusses professional strategy techniques that she has found useful through incredibly challenging times.
March 18, 2025
Article
P-BCMA-ALLO1 displayed high response rates and compelling safety in a heavily pretreated population of patients with relapsed/refractory multiple myeloma.
February 27, 2025
Video
Carrie L. Kitko, MD, discusses outcomes with axatilimab in patients with chronic graft-vs-host-disease according to prior lines of therapy received.
February 27, 2025
Article
Step-up dosing with etentamig produced responses and low rates of CRS in relapsed/refractory multiple myeloma.
February 20, 2025
Article
Networking is an underutilized skill that requires practice but can have a high impact on shaping your career path.
January 11, 2025
Video
Alan Tan, MD, discusses the IO-based combination therapies that are available for the treatment of patients with RCC.
December 06, 2024
Podcast
Drs Dhakal and Baljevic discuss first- and subsequent-line treatment options for patients with multiple myeloma.
November 22, 2024
Article
Douglas B. Johnson, MD, MSCI, unpacks NCCN guideline updates in melanoma, detailing how neoadjuvant and TIL therapies have been notable advancements.
October 18, 2024
Article
Alan Tan, MD, discusses the nuances of navigating combination regimens for patients with advanced renal cell carcinoma.
October 18, 2024
Article
Jill Gilbert, MD, highlights a recent landmark decision by the FDA concerning trial design moving forward for cancer drugs.
September 30, 2024
Video
Cathy Eng, MD, FACP, FASCO, discusses unmet needs within the metastatic colorectal cancer treatment paradigm.
August 15, 2024
Article
Brian Rini, MD, and Robert Uzzo, MD, MBA, FACS, highlight the utility of the potential biomarker KIM-1 in renal cell carcinoma.
July 23, 2024
Video
Brian I. Rini, MD, FASCO, discusses an analysis of clustering from the KEYNOTE-426 study in patients with advanced renal cell carcinoma.
July 21, 2024
Article
Brian Rini, MD, details recent data in renal cell carcinoma surrounding the utility of KIM-1 as a potential biomarker and next steps for KIM-1 research.
July 09, 2024
Video
Mary Philip, MD, PhD, discusses research on the key transcriptional and epigenetic programs that regulate CD8 T cell fate decisions in cancer models.
May 31, 2024
Video
Christine M. Lovly, MD, PhD, discusses the investigation of the EGFR inhibitor BDTX-1535 in patients with non–small cell lung cancer.